SCHEMBL7965183

SCHEMBL7965183

CSc1nn(-c2c(Cl)cc(Cl)cc2C(F)(F)F)c2ncnc(Cl)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 14/20 0.60
CCND1 P24385 14/20 0.60
CRHR1 P34998 1/20 0.51
CCNE2 O96020 8/20 0.50
CCNE1 P24864 8/20 0.50
CDK2 P24941 8/20 0.50
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
GABRP O00591 5/20 0.41
GABRD O14764 5/20 0.41
GABRA1 P14867 5/20 0.41
GABRB1 P18505 5/20 0.41
GABRG2 P18507 5/20 0.41
GABRB3 P28472 5/20 0.41
GABRA5 P31644 5/20 0.41
GABRA3 P34903 5/20 0.41
GABRA2 P47869 5/20 0.41
GABRB2 P47870 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965661 0.88 CDK4 (0.62) CDK4CCND1CRHR1CCNE2CCNE1
SCHEMBL7962588 0.76 CDK4 (0.62) CDK4CCND1CRHR1CCNE2CCNE1
SCHEMBL7961966 0.74 CDK4 (0.59) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL9285347 0.70 CDK4 (0.49) CDK4CCND1CRHR1GABRPGABRD
SCHEMBL7967756 0.70 GABRP (0.61) CDK4CCND1GABRPGABRDGABRA1
SCHEMBL7965911 0.69 CRHR1 (0.63) CDK4CCND1CRHR1CCNE2CCNE1
SCHEMBL7965665 0.69 CDK4 (0.56) CDK4CCND1CRHR1CCNE2CCNE1
SCHEMBL7577957 0.69 CRHR1 (0.54) CDK4CCND1CRHR1GABRPGABRD
SCHEMBL8113413 0.68 CDK4 (0.58) CDK4CCND1CRHR1CCNE2CCNE1
SCHEMBL8121281 0.68 CDK4 (0.53) CDK4CCND1CRHR1CCNE2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218397-B1 FOR THERAPY OF STRESS-RELATED ILLNESSES, SUCH AS STRESS-INDUCED DEPRESSION, ANXIETY, AND HEADACHE; ABDOMINAL BOWEL SYNDROME; INFLAMMATORY DISEASES; IMMUNE SUPPRESSION; ALZHEIMER'S DISEASE; GASTRONINTESTINAL DISEASES PFIZER INC 2001-04-17 US disclosed
EP-0674642-B1 PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS PFIZER (US) 2000-08-23 EP disclosed